Skip to main content

Maria Mar Hernandez Guillamon

Senior Researcher, Neurovascular Research Lab, VHIR.

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Maria Mar Hernandez Guillamon

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Senior Researcher, Neurovascular Research Lab, VHIR.

Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.

Projects

Angiopatía amieloide cerebral (AAC)

IP: Joan Montaner Villalonga
Collaborators: Maria Mar Hernandez Guillamon
Funding agency: Instituto de Salud Carlos III
Funding: 148377.88
Reference: CD06/00028
Duration: 01/01/2007 - 31/12/2010

Influencia de las Células Endoteliales Progenitoras sobre la Modulación Espacio-Temporal de la Angiogénesis y la Vasculogénesis tras el Ictus Isquémico Humano

IP: José Alvarez Sabin
Collaborators: Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez
Funding agency: Instituto de Salud Carlos III
Funding: 240185
Reference: PI060471
Duration: 01/01/2007 - 31/05/2010

Participación de sistemas proteolíticos en la progresión de la angiopatía amiloide cerebral

IP: Mercè Boada Rovira
Collaborators: Francesc Pujadas Navinés, Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez
Funding agency: Instituto de Salud Carlos III
Funding: 161535
Reference: PI070737
Duration: 01/01/2008 - 30/06/2011

RENEVAS - Red de Investigación Cooperativa Neurovascular

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 793573.69
Reference: RD06/0026/0010
Duration: 02/01/2007 - 31/12/2013

Related news

For three days, the III Stroke Congress of the national RICORS-ICTUS network and a symposium focused on cerebral haemorrhage were held.

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Almudena Sanchez Garcia

Almudena Sanchez Garcia

Research technician
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more
Romy Gander

Romy Gander

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Valentina Balasso

Valentina Balasso

Tècnic/a Superior Recerca
Ethics Committees Support Unit (USCE)
External Strategy Directorate
Read more
Elena Andretta

Elena Andretta

Research technician
Childhood Cancer and Blood Disorders
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.